If they don’t grow revenue and the A$ increased substantially ... yes, M7T could slip into a NPAT loss. BUT - under that scenario, M7T would still remain EBITDA, NPATDA and cash positive! Providing operating cash flow stays positive, M7T is derisked.
Therefore, IMO, Exchange rate risk is almost immaterial to M7Ts value. It’s all about how quickly they can grow revenue in constant currency.
If they don’t grow revenue and the A$ increased substantially...
Add M7T (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.010(2.78%) |
Mkt cap ! $89.25M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 37.0¢ | 36.5¢ | $79.14K | 216.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10974 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 81566 | 2 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| M7T (ASX) Chart |